Needham Maintains Buy on Veracyte, Raises Price Target to $44
Needham Maintains Buy on Veracyte, Raises Price Target to $44
Needham維持對veracyte的買入評級,並將目標股價上調至44美元
Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $37 to $44.
Needham分析師Mike Matson維持對Veracyte(納斯達克:VCYT)的買入評級,並將目標股價從37美元上調至44美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。